Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II

Sangamo Therapeutics · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
dnagene-editinggene-therapygenetic
mucopolysaccharidosis ii, mps ii, mps ll, hunter syndrome, gene editing, gene therapy, zinc finger, zfn, sb-913, rare, genetic, dna
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 902150
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.